New York, June 29, 2020 – Privately-held Guard Medical Inc. today announces a substantial cash infusion of $5 million following the achievement of the important milestone of FDA 510k clearance for its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
News
Guard Medical Announces FDA 510k clearance for its novel NPseal™, the first all-in-one NPWT surgical dressing
New York, June 15, 2020 – Privately-held company Guard Medical Inc. today announces FDA 510k clearance for its next generation Negative Pressure Wound Therapy (NPWT) dressing NPsealTM for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.